{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Victoria : Questions médicales les plus fréquentes",
"headline": "Victoria : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Victoria : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-03",
"dateModified": "2025-03-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Victoria"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Australie",
"url": "https://questionsmedicales.fr/mesh/D001315",
"about": {
"@type": "MedicalCondition",
"name": "Australie",
"code": {
"@type": "MedicalCode",
"code": "D001315",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Victoria",
"alternateName": "Victoria",
"code": {
"@type": "MedicalCode",
"code": "D014739",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Katherine B Gibney",
"url": "https://questionsmedicales.fr/author/Katherine%20B%20Gibney",
"affiliation": {
"@type": "Organization",
"name": "Victorian Government Department of Health and Human Services."
}
},
{
"@type": "Person",
"name": "Christopher M O'Connor",
"url": "https://questionsmedicales.fr/author/Christopher%20M%20O%27Connor",
"affiliation": {
"@type": "Organization",
"name": "Inova Heart and Vascular Institute, Falls Church, VA (C.M.O.)."
}
},
{
"@type": "Person",
"name": "Paul W Armstrong",
"url": "https://questionsmedicales.fr/author/Paul%20W%20Armstrong",
"affiliation": {
"@type": "Organization",
"name": "Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (J.E., C.M.W., P.W.A.)."
}
},
{
"@type": "Person",
"name": "Ben Beck",
"url": "https://questionsmedicales.fr/author/Ben%20Beck",
"affiliation": {
"@type": "Organization",
"name": "School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": "Duke Clinical Research Institute, Duke University, Durham, NC."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37746265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fonc.2023.1238883"
}
},
{
"@type": "ScholarlyArticle",
"name": "The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36219319",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11033-022-07903-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assay.",
"datePublished": "2024-04-16",
"url": "https://questionsmedicales.fr/article/38635397",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.xpro.2024.102987"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38988928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.21037/tcr-24-837"
}
},
{
"@type": "ScholarlyArticle",
"name": "A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37314501",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00280-023-04545-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Océanie",
"item": "https://questionsmedicales.fr/mesh/D044349"
},
{
"@type": "ListItem",
"position": 4,
"name": "Australasie",
"item": "https://questionsmedicales.fr/mesh/D044362"
},
{
"@type": "ListItem",
"position": 5,
"name": "Australie",
"item": "https://questionsmedicales.fr/mesh/D001315"
},
{
"@type": "ListItem",
"position": 6,
"name": "Victoria",
"item": "https://questionsmedicales.fr/mesh/D014739"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Victoria - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Victoria",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Victoria",
"description": "Comment diagnostiquer une maladie en Victoria ?\nQuels tests sont courants en Victoria ?\nY a-t-il des spécialistes en Victoria ?\nComment accéder aux soins de santé en Victoria ?\nQuelles sont les maladies courantes à diagnostiquer ?",
"url": "https://questionsmedicales.fr/mesh/D014739?mesh_terms=ErbB+Receptors&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Victoria",
"description": "Quels symptômes sont fréquents en Victoria ?\nComment reconnaître une infection respiratoire ?\nQuels symptômes d'allergies sont fréquents ?\nQuels symptômes indiquent une urgence médicale ?\nComment identifier une maladie chronique ?",
"url": "https://questionsmedicales.fr/mesh/D014739?mesh_terms=ErbB+Receptors&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Victoria",
"description": "Comment prévenir les maladies infectieuses ?\nQuelles sont les recommandations de santé publique ?\nComment réduire les risques d'allergies ?\nQuelles sont les mesures de sécurité en santé ?\nComment promouvoir la santé mentale ?",
"url": "https://questionsmedicales.fr/mesh/D014739?mesh_terms=ErbB+Receptors&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Victoria",
"description": "Quels traitements sont disponibles en Victoria ?\nComment sont gérées les maladies chroniques ?\nY a-t-il des traitements alternatifs en Victoria ?\nQuels médicaments sont couramment prescrits ?\nComment se déroule une thérapie physique ?",
"url": "https://questionsmedicales.fr/mesh/D014739?mesh_terms=ErbB+Receptors&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Victoria",
"description": "Quelles complications peuvent survenir après une infection ?\nComment gérer les complications d'une maladie chronique ?\nQuelles complications peuvent résulter d'une chirurgie ?\nComment prévenir les complications liées au diabète ?\nQuelles complications peuvent survenir avec des allergies ?",
"url": "https://questionsmedicales.fr/mesh/D014739?mesh_terms=ErbB+Receptors&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Victoria",
"description": "Quels sont les facteurs de risque pour les maladies cardiovasculaires ?\nComment le mode de vie influence-t-il la santé ?\nQuels facteurs de risque sont liés aux allergies ?\nComment l'âge influence-t-il la santé ?\nQuels sont les risques liés à la consommation d'alcool ?",
"url": "https://questionsmedicales.fr/mesh/D014739?mesh_terms=ErbB+Receptors&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie en Victoria ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, les antécédents médicaux et des tests spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont courants en Victoria ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins, les imageries médicales et les biopsies sont fréquemment utilisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des spécialistes en Victoria ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Victoria dispose de nombreux spécialistes dans divers domaines médicaux."
}
},
{
"@type": "Question",
"name": "Comment accéder aux soins de santé en Victoria ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins peuvent être obtenus via des hôpitaux publics, des cliniques privées ou des généralistes."
}
},
{
"@type": "Question",
"name": "Quelles sont les maladies courantes à diagnostiquer ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies respiratoires, cardiovasculaires et infectieuses sont fréquentes en Victoria."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont fréquents en Victoria ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes courants incluent la toux, la fièvre et la fatigue, selon les maladies."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection respiratoire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent toux persistante, essoufflement et douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'allergies sont fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les démangeaisons, les éternuements et les éruptions cutanées sont courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une urgence médicale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs thoraciques sévères, difficultés respiratoires ou perte de conscience nécessitent une attention immédiate."
}
},
{
"@type": "Question",
"name": "Comment identifier une maladie chronique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes persistants comme la fatigue, la douleur et les troubles du sommeil peuvent indiquer une maladie chronique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies infectieuses ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène et l'évitement des contacts avec des personnes malades sont essentiels."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations de santé publique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les recommandations incluent une alimentation équilibrée, l'exercice régulier et des contrôles de santé."
}
},
{
"@type": "Question",
"name": "Comment réduire les risques d'allergies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les allergènes connus et maintenir un environnement propre aide à réduire les risques."
}
},
{
"@type": "Question",
"name": "Quelles sont les mesures de sécurité en santé ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en milieu médical."
}
},
{
"@type": "Question",
"name": "Comment promouvoir la santé mentale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager le soutien social, la gestion du stress et l'accès à des ressources de santé mentale."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles en Victoria ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la médication, la thérapie physique et la chirurgie selon les besoins."
}
},
{
"@type": "Question",
"name": "Comment sont gérées les maladies chroniques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont gérées par des plans de traitement personnalisés, incluant médicaments et suivi régulier."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs en Victoria ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements alternatifs comme l'acupuncture et l'homéopathie sont disponibles."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont couramment prescrits ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques, les analgésiques et les antihistaminiques sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Comment se déroule une thérapie physique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle implique des exercices, des étirements et des techniques manuelles pour améliorer la mobilité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une infection ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une maladie chronique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et des ajustements de traitement sont nécessaires pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une chirurgie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, saignements et réactions anesthésiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées au diabète ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un contrôle glycémique rigoureux et des examens réguliers aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des allergies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions anaphylactiques et des complications respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les maladies cardiovasculaires ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension, le tabagisme, l'obésité et le diabète augmentent le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il la santé ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire, une mauvaise alimentation et le stress augmentent les risques de maladies."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont liés aux allergies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'exposition à des allergènes et la pollution augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il la santé ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé est un facteur de risque pour de nombreuses maladies, y compris les maladies chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les risques liés à la consommation d'alcool ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive d'alcool peut entraîner des maladies du foie, des cancers et des troubles mentaux."
}
}
]
}
]
}
Hepatocellular carcinoma (HCC) patients at advanced stages receive immunotherapy or treatment with tyrosine kinase inhibitors (TKIs) such as Sorafenib (Sora) or Lenvatinib in frontline as well as Rego...
In this study, we addressed the impact of the receptor tyrosine kinase Axl binding to its ligand Gas6 in acquiring refractoriness to TKIs. The initial responses of Axl-positive and Axl-negative cell l...
We show that HCC cells exhibiting a mesenchymal-like phenotype were less sensitive to drug treatment, linking TKI resistance to changes in epithelial plasticity. Gas6/Axl expression and activation wer...
Together, these data suggest that the inhibition of ErbBs is synthetic lethal with Rego in Axl-expressing HCC cells, showing a novel vulnerability of HCC....
Glioblastoma multiforme (GBM) is an aggressive and lethal brain cancer, which is incurable with standard cancer treatments. miRNAs have great potential to be used for gene therapy due to their ability...
Here, miR-429 was overexpressed using lentiviral vectors in U-251 and U-87 GBM cells and it was observed that the expression level of several oncogenes of the ERBB pathway, EGFR, PIK3CA, PIK3CB, KRAS,...
Altogether, miR-429 seems to be an efficient suppressor of the ERBB genetic signaling pathway and a potential therapeutic for GBM....
The ERBBprofiler assay measures compound effects on ERBB family receptors and key downstream signaling pathways that are implicated in cancer or other complex diseases. Here, we present a protocol for...
Hepatocellular carcinoma (HCC) is a highly heterogeneous and aggressive tumor. In recent years, the incidence of HCC has been increasing worldwide. Despite notable advancements in treatment methodolog...
We performed a comprehensive, narrative review of the latest literature to define the current progress of ErbB family receptors in HCC in both the pre-clinical and clinical arenas....
The ErbB family belongs to the tyrosine kinase (TK) receptor family that comprises four members. These members are closely associated with proliferation, cell cycle regulation, and migration during HC...
Through in-depth research and the application of ErbB-targeted therapy, broader avenues will be opened for the treatment of HCC and other tumors, leading to more personalized and precise treatment app...
Aberrant alterations of ERBB receptor tyrosine kinases lead to tumorigenesis. Single agent therapy targeting EGFR or HER2 has shown clinical successes, but drug resistance often develops due to aberra...
Patients with actionable somatic mutations or amplifications in ERBB genes or actionable KRAS mutations were enrolled to receive neratinib and trametinib in this phase I dose escalation trial. The pri...
Twenty patients were enrolled with a median age of 50.5 years and a median of 3 lines of prior therapy. Grade 3 treatment-related toxicities included: diarrhea (25%), vomiting (10%), nausea (5%), fati...
Neratinib and trametinib combination was toxic and had limited clinical efficacy. This may be due to suboptimal drug dosing given drug-drug interactions....
NCT03065387....
ERBB receptor tyrosine kinases are involved in development and diseases like cancer, cardiovascular, neurodevelopmental, and mental disorders. Although existing drugs target ERBB receptors, the next g...
Gallbladder cancer (GBC) is an aggressive type of digestive system cancer with a dismal outcome. Given the lack of effective treatment options, the disease rapidly reoccurs and 5-year survival rate is...
We conduct a multicentre and randomised study on afatinib combined with gemcitabine and oxaliplatin (GEMOX) in patients with ErbB pathway mutated GBC. Clinical and biological evaluation involving ErbB...
The study was approved by the medical-ethical review committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and Renji Hospital Affiliated to Shanghai Jiao Tong Uni...
NCT04183712....
Epidermal growth factor receptor (EGFR), which is referred to as ErbB1/HER1, is the prototype of the EGFR family of receptor tyrosine kinases which also comprises ErbB2 (Neu, HER2), ErbB3 (HER3), and ...
Current therapies targeting the human epidermal growth factor receptor (HER) family, including monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs), are limited by drug resistance and sy...
Transactivation of epidermal growth factor receptors (EGFR) provides intricate control over multiple regulatory cellular processes that merge the diversity of G protein-coupled receptors (GPCRs) with ...